Back

Cytotoxic and regulatory CD8 T cells dynamics underlies ICI-myotoxicity outcome

Wang, R.; Xiang, C.; Procureur, A.; Sanchez-Dal Cin, J.; Hong, S.-m.; Zhang, B.; Lin, X.; Lian, X.; Liu, G.; Wu, W.; Chen, X.; Xiao, X.; Chen, X.; Wang, X.; Rosenzwajg, M.; Allenbach, Y.; Fu, Q.; Shen, N.; Salem, J.-E.; Ye, S.

2026-03-10 rheumatology
10.64898/2026.03.03.26347221 medRxiv
Show abstract

Immune checkpoint inhibitor-induced myotoxicity (ICI-M) comprises myocarditis, myositis, and myasthenia gravis-like syndrome, demanding rapid recognition and therapy. Using immunophenotyping and transcriptomics analysis from blood and muscle, we identified distinct CD38hi and KIR+ CD8 T cells in ICI-M. Abatacept rescued patients and altered the composition and clonality of these cells. Dynamics of CD38hi and KIR+ CD8 T cells effectively supported therapeutic monitoring, offering personalized treatment in life-threatening irAEs.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.